UK healthcare workers who receive seasonal influenza vaccination are less likely to contract influenza than their ...

Australian biotech giant CSL said on Tuesday it plans to demerge its influenza vaccine division, CSL Seqirus, into a separately listed company by the end of the financial year 2026, alongside job cuts ...

If you are in one of 34 states, you can now order AstraZeneca's FluMist Home vaccine online to be delivered to your home ...

Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company focused on recombinant protein-based vaccines using nanoparticle and ...

The FDA approved AstraZeneca’s no-prescription FluMist vaccine in September 2024. Now with FluMist Home, people can have it ...

Yes, the flu shot is still a thing. And four doctors we spoke to said they recommend you get your flu shot this year.

Australia’s largest pharmaceutical company plans to spin off its Seqirus business into a separate ASX listing in the 2026 ...

The vaccine requires a prescription, which people can obtain by filling out a medical screening questionnaire through the ...

CSL also said it would restart a multi-year share buyback program from FY26, beginning with A$750 million. Chief Executive ...

The approval of the new nasal spray comes ahead of this year's influenza season in hopes to prevent the unusually high ...

Australian biotech giant CSL Ltd on Tuesday announced plans to demerge its influenza vaccine division, CSL Seqirus, and said it will lay off up to 15% of its workforce, after reporting a strong growth ...

HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...